Concurrent Session 1: Allied Health / Nursing Session

Alternative Donors in Allogeneic Stem Cell Transplant
Linda Schroeder 

CAR-T and BiTE Therapy in Myeloma
Rebecca Malloy

What Happens After CAR-T Therapy Failure in Lymphoma?
Andrea Fadel

*MOC Credit not offered for this session

Mylove Mortel, MSPH, RN, OCN (Moderator)

Assistant Director, Transplant & Cell Therapy Clinical Operations

University of Chicago Medicine

Mylove Mortel, MS, RN, OCN is the clinical operations lead for the Cellular Therapy Program at the University of Chicago Medicine and has a demonstrated history of working in stem cell transplant and cellular therapy covering both investigational and commercial products. She has a strong interest in program development, strategic planning, data analytics, outcomes research, and quality. She has a Master of Science in Public Health (major in Epidemiology) and undergraduate degrees in Nursing and Mathematics. 

Linda Schroeder

Nurse

University of Chicago Medicine

Rebecca Malloy, BSN

Cellular Therapy/Multiple Myeloma Nurse Coordinator

University of Chicago Medicine

Andrea Fadel, BSN

Transplant and Cellular Therapy Nurse Coordinator

University of Chicago Medicine

Key:

Complete
Failed
Available
Locked
Concurrent Session 1: Allied Health / Nursing Session
02/24/2023 at 10:30 AM (EST)  |  Recorded On: 03/01/2023
02/24/2023 at 10:30 AM (EST)  |  Recorded On: 03/01/2023 *MOC Credit not available for this session
You must register to access.